MSD is expecting to see an additional $200 million layered onto its costs this year as a result of President Trump's tariffs – even before a possible pharma-specific levy is announced. The US pharma ...

MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage ...

MSD's booth is seen during an expo in Shanghai in November. [PHOTO/CHINA DAILY] With a long-term commitment to the Chinese market, United States-based global pharmaceutical company MSD plans to ...

A high-level overview of MS Emerging Markets Debt Fund (MSD). Stay up to date on the latest price, chart, news, analysis, fundamentals, trading and investment tools.

From your favorite retro console to the latest releases, The Escapist covers everything in the world of video games across news, reviews, features, and guides. Our team of experts has been playing ...